Electrophysiology Devices Market Report and Forecast 2023-2031

Global Electrophysiology Devices Market Outlook

The global electrophysiology devices market value was USD 6.17 billion in 2022, driven by the increasing prevalence of cardiac arrhythmias across the globe. The market size is anticipated to grow at a CAGR of 10% during the forecast period of 2023-2031 to achieve a value of USD 14.5 billion by 2031.

Electrophysiology Introduction

Electrophysiology is a branch of cardiology that deals with the study, diagnosis, and treatment of cardiac electrical activity and abnormal heart rhythms, also known as arrhythmias. The electrophysiology devices market primarily comprises diagnostic and therapeutic devices used in electrophysiological procedures. Diagnostic devices include electrophysiology (EP) recording systems, EP mapping systems, and intracardiac echocardiography systems. Therapeutic devices consist of cardiac ablation catheters, pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices.

Electrophysiology Devices Market Scenario

The global electrophysiology devices market has experienced significant growth in recent years, driven by factors such as the increasing prevalence of cardiac arrhythmias, advancements in electrophysiology technologies, and the growing demand for minimally invasive procedures.

North America: The largest market for electrophysiology, driven by factors such as the advanced healthcare infrastructure, a high prevalence of cardiac arrhythmias, and the presence of major electrophysiology device manufacturers.

Europe: The second-largest market, with increasing demand for electrophysiology devices due to a growing aging population and a supportive regulatory framework.

Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.

Electrophysiology Devices Market Segmentations

Market Breakup by Type

Treatment Devices

Implantable Cardioverter Defibrillators (ICDs)
Automated external defibrillators (AEDs)
Pacemakers
CRT-P
CRT-D
Catheters
Others

Diagnostic Devices

Holter Monitoring Devices
Diagnostic Electrophysiology Catheters
Electrocardiograph (ECG)
EP Mapping & Imaging Systems
Insertable cardiac monitors (ICM)
Others

Market Breakup by Indication

Atrial Fibrillation (AF)
Supraventricular Tachycardia (SVT)
Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)
Wolff-Parkinson-White Syndrome (WPW)
Bradycardia
Others

Devices Market Breakup by End User

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others

Market Breakup by Region

North America

United States of America
Canada

Europe

United Kingdom
Germany
France
Italy
Others

Asia Pacific

China
Japan
India
ASEAN
Australia
Others

Latin America

Brazil
Argentina
Mexico
Others

Middle East and Africa

Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others

Key Trends in the Electrophysiology Devices Market

Some key trends of the market are as follows:

Advancements in electrophysiology technologies: The development of new technologies, such as 3D mapping systems, high-resolution imaging, and remote navigation systems, has improved the accuracy, safety, and efficiency of electrophysiological procedures, contributing to market expansion
Growing demand for minimally invasive procedures: The increasing preference for minimally invasive electrophysiological procedures, such as catheter ablation, has driven market growth and innovation
Increasing prevalence of cardiac arrhythmias: The rising prevalence of cardiac arrhythmias, particularly atrial fibrillation, among the aging global population has led to greater demand for advanced diagnostic and therapeutic electrophysiology solutions

Electrophysiology Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

Johnson & Johnson Private Limited
BIOTRONIK SE & Co KG
Abbott
Medtronic
Boston Scientific Corporation
B. Braun Melsungen AG
BD
Baxter
Koninklijke Philips N.V
General Electric
Medline Industries, Inc
Danaher
Siemens Healthcare GmbH
MicroPort Scientific Corporation
LivaNova PLC
Cardiofocus
Mogul Enterprises, Inc
AtriCure, Inc
Japan Lifeline Co., Ltd
ARGON MEDICAL

1 Preface

1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology

2 Executive Summary

3 Global Electrophysiology Devices Market Overview

3.1 Global Electrophysiology Devices Market Historical Value (2016-2022)
3.2 Global Electrophysiology Devices Market Forecast Value (2023-2031)

4 Global Electrophysiology Devices Market Landscape

4.1 Global Electrophysiology Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Electrophysiology Devices Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indication
4.2.3 Analysis by End User

5 Global Electrophysiology Devices Market Dynamics

5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis

6 Global Electrophysiology Devices Market Segmentation

6.1 Global Electrophysiology Devices Market, by Type
6.1.1 Market Overview
6.1.2 Treatment Devices
6.1.2.1 Implantable Cardioverter Defibrillators (ICDs)
6.1.2.2 Automated external defibrillators (AEDs)
6.1.2.3 Pacemakers
6.1.2.3.1 CRT-P
6.1.2.3.2 CRT-D
6.1.2.3.3 Catheters
6.1.2.3.4 Others
6.1.3 Diagnostic Devices
6.1.3.1 Holter Monitoring Devices
6.1.3.2 Diagnostic Electrophysiology Catheters
6.1.3.3 Electrocardiograph (ECG)
6.1.3.4 EP Mapping & Imaging Systems
6.1.3.5 Insertable cardiac monitors (ICM)
6.1.3.6 Others
6.2 Global Electrophysiology Devices Market, by Indication
6.2.1 Market Overview
6.2.2 Atrial Fibrillation (AF)
6.2.3 Supraventricular Tachycardia (SVT)
6.2.4 Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)
6.2.5 Wolff-Parkinson-White Syndrome (WPW)
6.2.6 Bradycardia
6.2.7 Others
6.3 Global Electrophysiology Devices Market, by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Ambulatory Surgical Centers
6.3.5 Others
6.4 Global Electrophysiology Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa

7 North America Electrophysiology Devices Market

7.1 Market Share by Country
7.2 United States of America
7.3 Canada

8 Europe Electrophysiology Devices Market

8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others

9 Asia Pacific Electrophysiology Devices Market

9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others

10 Latin America Electrophysiology Devices Market

10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others

11 Middle East and Africa Electrophysiology Devices Market

11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others

12 Patent Analysis

12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players

13 Grants Analysis

13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization

14 Funding Analysis

14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography

15 Partnership and Collaborations Analysis

15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography

16 Regulatory Framework

16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others

17 Supplier Landscape

17.1 Johnson & Johnson Private Limited
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 BIOTRONIK SE & Co KG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Abbott
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Boston Scientific Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B. Braun Melsungen AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 BD
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Baxter
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Koninklijke Philips N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 General Electric
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Medline Industries, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Danaher
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Siemens Healthcare GmbH
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 MicroPort Scientific Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 LivaNova PLC
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Cardiofocus
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Mogul Enterprises, Inc.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 AtriCure, Inc.
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 Japan Lifeline Co., Ltd.
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 ARGON MEDICAL
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications

18 Global Electrophysiology Devices Market-Distribution Model (Additional Insight)

18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment

19 Key Opinion Leaders (KOL) Insights (Additional Insight)

20 Company Competitiveness Analysis (Additional Insight)

20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies

21 Pricing Models and Strategies (Additional Insight)

21.1 Overview
21.2 Cost Model
21.2.1 Manufacturing Cost Analysis
21.2.2 Procurement Cost Analysis
21.2.3 Clinical Trial Cost Factors
21.3 Pricing Strategies
21.3.1 Competitor Pricing Analysis
21.3.2 Key Assessment of Product Attributes
21.3.3 Pricing Benchmark

Companies Mentioned

Abbott Laboratories
Siemens Healthcare AG
Nihon Kohden Corporation
Boston Scientific Corporation
General Electric Company
Medtronic plc
Koninklijke Philips N.V.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	140
Published	May 2023
Forecast Period	2023 - 2031
Estimated Market Value ( USD ) in 2023	$ 6.8 Billion
Forecasted Market Value ( USD ) by 2031	$ 14.5 Billion
Compound Annual Growth Rate	10.0%
Regions Covered	Global
No. of Companies Mentioned	7

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5740EUR$5,999USD£4,776GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7654EUR$7,999USD£6,369GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9568EUR$9,999USD£7,961GBP